Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE49.300.3 (+0.61 %)
PREV CLOSE ( ) 49.00
OPEN PRICE ( ) 50.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 77882
TODAY'S LOW / HIGH ( )48.90 50.75
52 WK LOW / HIGH ( )43.4 97.5
NSE49.250.25 (+0.51 %)
PREV CLOSE( ) 49.00
OPEN PRICE ( ) 49.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 49.25 (234)
VOLUME 460112
TODAY'S LOW / HIGH( ) 48.80 50.05
52 WK LOW / HIGH ( )43.55 97.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email info@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

12May Announcement under Regulation 30 (LOD
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Intent..
25Apr Marksans Pharma inks pact to acquire 1
Marksans Pharma has signed a share purchase agreement to acquire a 100%..
25Apr Marksans Pharma informs about disclosure
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
25Apr Announcement under Regulation 30 (LOD
Intimation under Regulation 30 read with Schedule III of SEBI (Listing O..
14Apr Marksans Pharma informs about non- app
Marksans Pharma has confirmed that the company is not a Large Corporate..

Financials

in Millions
QTR Dec 21 ANNUAL 21
Net Profit260.57983.81
Gross Profit 346.79 1243.3
Operating Profit 398.851448.68
Net Sales 1659.375995.48

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  2648.00 (3.33%)
M.Cap ( in Cr)6620.00
Pfizer (BSE)
peergroup  4407.35 (1.27%)
M.Cap ( in Cr)20162.63
Sanofi India (BSE)
peergroup  6636.45 (0.82%)
M.Cap ( in Cr)15284.16
Dr. Reddy's Lab (BSE)
peergroup  4274.25 (0.66%)
M.Cap ( in Cr)71134.57
Kwality Pharma (BSE)
peergroup  397.25 (5.00%)
M.Cap ( in Cr)412.19

Shareholding Pattern

PROMOTERS 48.25%
NON-INSTITUTION 47.67%
MUTUAL FUNDS/UTI 0.46%
GOVERNMENT 0.15%
FI/BANKS/INSURANCE 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Quant Small Cap Fund(G)0.52

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 49.3. Its current market capitalisation stands at Rs 2017.92 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5995.48 Cr and Total Income of Rs.6307.03 Cr. The company's management includes Sunny Sharma, Harshavardhan Panigrahi, Meena Surana, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)